Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP637037.RAX57RsXVnP6V3_WgnbHbwnTtx0xeoSzRnLyrG1RuRLjU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP637037.RAX57RsXVnP6V3_WgnbHbwnTtx0xeoSzRnLyrG1RuRLjU130_assertion type Assertion NP637037.RAX57RsXVnP6V3_WgnbHbwnTtx0xeoSzRnLyrG1RuRLjU130_head.
- NP637037.RAX57RsXVnP6V3_WgnbHbwnTtx0xeoSzRnLyrG1RuRLjU130_assertion description "[In addition, most of the gastric adenocarcinoma cases with CD99 down-regulation had reduced expression of SP1 (47 of 103, 45.6%; P<0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637037.RAX57RsXVnP6V3_WgnbHbwnTtx0xeoSzRnLyrG1RuRLjU130_provenance.
- NP637037.RAX57RsXVnP6V3_WgnbHbwnTtx0xeoSzRnLyrG1RuRLjU130_assertion evidence source_evidence_literature NP637037.RAX57RsXVnP6V3_WgnbHbwnTtx0xeoSzRnLyrG1RuRLjU130_provenance.
- NP637037.RAX57RsXVnP6V3_WgnbHbwnTtx0xeoSzRnLyrG1RuRLjU130_assertion SIO_000772 17473187 NP637037.RAX57RsXVnP6V3_WgnbHbwnTtx0xeoSzRnLyrG1RuRLjU130_provenance.
- NP637037.RAX57RsXVnP6V3_WgnbHbwnTtx0xeoSzRnLyrG1RuRLjU130_assertion wasDerivedFrom befree-20140225 NP637037.RAX57RsXVnP6V3_WgnbHbwnTtx0xeoSzRnLyrG1RuRLjU130_provenance.
- NP637037.RAX57RsXVnP6V3_WgnbHbwnTtx0xeoSzRnLyrG1RuRLjU130_assertion wasGeneratedBy ECO_0000203 NP637037.RAX57RsXVnP6V3_WgnbHbwnTtx0xeoSzRnLyrG1RuRLjU130_provenance.